---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-058258"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2026-08-20T20:25:39+00:00"
generated_at: "2026-08-20T20:27:09.661949+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Senti Biosciences subsidiary issues $4.0M convertible notes to Celadon; potential $60M CVR merger pending

## Summary
- On Aug 14, 2026, Senti Holdings issued $4.0M principal Senior Secured Convertible Notes to Celadon Partners SPV 24.
- Issuance under April 27, 2026 Securities Purchase Agreement; terms referenced from prior 8-Ks filed May 1 and May 26, 2026.
- Potential deal: Celadon affiliate to merge with Senti Holdings, issuing CVR worth up to $60M upon SENTI-202 regulatory/sales milestones.
- Preliminary proxy statement filed July 21, 2026; definitive proxy will be mailed to stockholders for vote.

## SEC filing metadata
- accession: 0001628280-26-058258
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2026-08-20T20:25:39+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000162828026058258/0001628280-26-058258-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000162828026058258/snti-20260814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-058258
- JSON: https://secwatch.observer/filing/0001628280-26-058258.json
- Plain text: https://secwatch.observer/filing/0001628280-26-058258.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.